Theralase Technologies Inc.
TLT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -655.90K | -687.40K | -828.50K | -939.50K | -728.40K |
| Total Depreciation and Amortization | 49.00K | 50.10K | 49.10K | 50.50K | 52.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.30K | 87.70K | 63.10K | 113.40K | 108.80K |
| Change in Net Operating Assets | 139.80K | -455.80K | 420.00K | -34.20K | -349.60K |
| Cash from Operations | -326.70K | -1.01M | -296.40K | -809.90K | -916.50K |
| Capital Expenditure | -4.90K | -6.30K | -600.00 | -2.70K | -8.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.90K | -6.30K | -600.00 | -2.70K | -8.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -48.00K | -23.50K | -23.00K | -22.60K | -52.70K |
| Issuance of Common Stock | 453.50K | 1.30M | 743.40K | 1.19M | 1.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00K | -- | -- | -- | 0.00 |
| Cash from Financing | 288.30K | 939.30K | 526.40K | 864.80K | 784.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | -43.40K | -72.50K | 229.40K | 52.30K | -140.50K |
